Early Administration of ATG Followed by Cyclophosphamide, Busulfan and Fludarabine Before a Donor Stem Cell Transplant in Patients With Hematological Cancer

Clinical Trial ID NCT00787761

Rank	Title	Journal	Year	PubWeight™‹?›
1	Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects.	Blood	2001	4.65
2	Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases.	Blood	1998	4.41
3	Engraftment of allogeneic hematopoietic progenitor cells with purine analog-containing chemotherapy: harnessing graft-versus-leukemia without myeloablative therapy.	Blood	1997	3.14
4	Stable mixed hematopoietic chimerism in DLA-identical littermate dogs given sublethal total body irradiation before and pharmacological immunosuppression after marrow transplantation.	Blood	1997	2.74
5	Stem cell transplantation in the normal nonmyeloablated host: relationship between cell dose, schedule, and engraftment.	Exp Hematol	1997	1.12
6	Reduced-intensity conditioning followed by allogeneic hematopoietic cell transplantation in myeloid diseases.	Ann Hematol	2003	0.80
7	Nonmyeloablative preparative regimens for allogeneic hematopoietic transplantation. Biology and current indications.	Oncology (Williston Park)	2003	0.78
8	Non-myeloablative allogeneic transplantation -- state-of-the-art.	Pediatr Transplant	2004	0.75